Generalized tetanus is a life-threatening, vaccine-preventable neurological infection caused by the neurotoxin (tetanospasmin) of Clostridium tetani. It is characterized by widespread painful muscle spasms, rigidity, trismus, and autonomic dysfunction, and constitutes a medical emergency requiring ICU-level care. [1-2]
1. History
- Port of entry: Ask about any wound, cut, abrasion, puncture, or skin break in the preceding 3 weeks (incubation period 3–21 days, median ~7 days); also ask about motorbike accidents, piercings, acupuncture, subcutaneous/intramuscular injections, dental procedures, and chronic skin ulcers [2-3]
- Up to 30% of patients have no identifiable wound at presentation [2]
- Symptom characterization: Jaw stiffness (trismus/lockjaw) → neck stiffness → back/abdominal pain → generalized rigidity → painful spasms triggered by noise, light, or touch [2]
- Timing: Onset typically cephalocaudal; spasms peak in the second week of illness [2]
- Period of onset (first symptom → first spasm): <48 hours = poor prognosis [4]
- Vaccination history: Determine primary series completion, last booster, and any prior tetanus episodes; tetanus can occur even in partially vaccinated individuals [3]
- Important negatives: Preserved consciousness (lucidity is maintained — obtundation suggests an alternative diagnosis), no sensory deficits [2]
2. Alarm Features
- Respiratory compromise: Dyspnoea, apnoeic spells, laryngospasm — risk of sudden airway obstruction [2][4]
- Autonomic nervous system dysfunction (ANSD): Labile blood pressure, tachycardia alternating with bradycardia, profuse sweating, fever >40°C — the most feared complication and leading cause of death in ventilated patients [2]
- Rapid symptom evolution: Incubation period <7 days and period of onset <48 hours predict severe disease [3-4]
- Severe dysphagia with aspiration risk [2]
- Opisthotonus (extreme hyperextension) — a late and ominous sign [2]
- Rhabdomyolysis from prolonged spasms → acute kidney injury [3]
- Cardiovascular events: Takotsubo cardiomyopathy (most common cardiac complication), arrhythmias, sudden cardiac arrest — occur days 5–20 of illness [5]
3. Medications
Acute Treatment:
- Human tetanus immunoglobulin (hTIG): 500 IU IM (single dose); equine antitoxin if hTIG unavailable [2-3]
- Metronidazole: 500 mg IV q6h × 10 days (preferred antibiotic; penicillin is an alternative but may theoretically worsen spasms via GABA antagonism) [1][3]
- Benzodiazepines (first-line spasm control): Diazepam 10–30 mg IV q1–4h PRN, or midazolam infusion; doses often exceed 1 mg/kg/day of diazepam [2-3]
- Neuromuscular blocking agents (severe/refractory spasms): Vecuronium or rocuronium preferred (cardiovascularly inert); requires mechanical ventilation [2-3]
- Propofol: Second-line sedation/spasm control [3]
- Magnesium sulfate: Adjunct for spasm control and autonomic dysfunction [3-4]
- Labetalol: For sympathetic hyperactivity [3]
- Intrathecal baclofen: Considered for refractory spasms, though not widely practiced [2-3]
Medications to Avoid/Use with Caution:
- Pancuronium (exacerbates autonomic instability) [3]
- Phenothiazines (lower seizure threshold, rarely used) [2]
Vaccination:
- Td or Tdap 0.5 mL IMLancet Infect Dis + 1[2-3]
4. Diet
- NPO initially in patients with significant trismus or dysphagia due to aspiration risk [3]
- Enteral feeding via soft, small-bore nasogastric tube or parenteral nutrition via central venous catheter as soon as feasible [3]
- Hydration: Aggressive IV fluid management; patients have high metabolic demands from sustained muscle contraction and sweating
- Long-term: Resume oral diet only after spasms and dysphagia have resolved
5. Review of Systems
- Neurological: Jaw stiffness, difficulty opening mouth, difficulty swallowing, voice changes, back pain, abdominal pain, muscle stiffness/spasms; preserved consciousness [2]
- Respiratory: Dyspnoea, choking episodes, apnoeic spells
- Cardiovascular: Palpitations, chest pain (Takotsubo), diaphoresis [5]
- GU: Urinary retention (autonomic dysfunction) [2]
- GI: Abdominal rigidity (can mimic acute abdomen), fecal incontinence [2-3]
- Constitutional: Fever (if early/high-grade, consider alternative diagnosis or superinfection) [2]
6. Collateral History and Family History
- Collateral: Confirm vaccination records; obtain details of wound/injury from witnesses; inquire about injection drug use, gardening/farming activities, animal exposure [2]
- Family history: Not directly hereditary, but household vaccination status and shared environmental exposures (rural, agricultural) are relevant
- Social context: Rural residence, farming occupation, low socioeconomic status, and injection drug use are strongly associated [2][6]
7. Risk Factors
- Incomplete or absent vaccination (most important risk factor) — 95% of patients in some series had no prior immunization [7]
- Older age (waning immunity; elderly have lowest seroprotection rates) [2]
- Male sex [2]
- Rural residence / farming / gardening injuries [2][6]
- Injection drug use (skin-popping) [2]
- Immunosuppression (diabetes, HIV, chronic steroid use) [2-3]
- Chronic wounds (venous ulcers, diabetic foot ulcers) [8]
- Penetrating wounds, crush injuries, burns, surgical wounds [4]
- Comorbidities: Diabetes, cardiovascular disease worsen prognosis [3]
8. Differential Diagnosis
- Strychnine poisoning — virtually indistinguishable; rapid onset (<30 min of ingestion); absence of tonic contraction between spasms; positive serum/urine assay [2]
- Neuroleptic malignant syndrome (NMS) — altered mental status, gradual onset, very high CK, medication history [2]
- Drug-induced dystonia (phenothiazines, metoclopramide) — absence of trismus, rapid response to anticholinergics (procyclidine/diphenhydramine) [2][4]
- Hypocalcemic tetany — low serum calcium, absence of trismus, Chvostek/Trousseau signs [2]
- Stiff-person syndrome — positive GAD antibodies, absence of trismus [2]
- Progressive encephalomyelitis with rigidity and myoclonus (PERM) — positive anti-glycine antibodies, altered mental status [2]
- Cerebral malaria — altered mental status, seizures, parasitemia on smear [2]
- Peritonitis/acute abdomen — rigid abdomen from tetanus can mimic surgical abdomen; unnecessary laparotomies have been reported [2-3]
- Meningitis — fever, altered mental status, CSF abnormalities (CSF is normal in tetanus) [3]
Key distinguishing feature of tetanus: Preserved consciousness with trismus + generalized rigidity + stimulus-provoked spasms [2]
9. Past Medical History
- Prior tetanus episodes (does NOT confer immunity — full re-vaccination required) [2]
- Vaccination history (primary series, last booster)
- Chronic wounds, recent surgeries (including colorectal surgery — documented as a rare portal of entry) [3]
- Diabetes, immunosuppressive conditions
- Injection drug use history
- Prior ICU admissions, intubation history
10. Physical Exam
Vital Signs:
Key Findings:
- Trismus (lockjaw) — present in 93–98% at admission [4]
- Risus sardonicus — sustained facial muscle spasm producing a grimacing smile [2]
- Generalized rigidity — board-like abdominal rigidity persisting between spasms [2][4]
- Opisthotonus — arched back from extensor spasm (late sign) [2]
- Hyper-reflexia with bilateral hypertonia [2]
- Stimulus-provoked spasms — triggered by noise, light, or touch [2]
- Preserved sensorium — patient is alert and oriented [2]
- Wound inspection: Look for any wound, even minor/healed; check extremities, feet, chronic ulcers
Concerning Findings:
- Apnoeic spells, stridor, or inability to handle secretions → impending airway loss
- Profuse diaphoresis, urinary retention → autonomic dysfunction [2]
11. Lab Studies
Recommended Labs:
- CBC (mild leukocytosis common; neutrophilia = poor prognostic indicator) [2]
- BMP (electrolytes, BUN, creatinine — assess for AKI) [3]
- Creatine kinase (elevated from rhabdomyolysis) [2-3]
- Calcium (to exclude hypocalcemic tetany) [2]
- Magnesium (baseline and monitoring during MgSO₄ therapy) [2]
- CRP, procalcitonin (to assess for superinfection; CRP usually moderately elevated) [2-3]
- Urinalysis — assess for myoglobinuria (proxy for rhabdomyolysis) [2]
- Blood gas analysis [2]
- LFTs [2]
Rule-Out Labs:
- Serum/urine strychnine assay if poisoning suspected [2]
- Serum calcium to exclude tetany [2]
- Anti-GAD and anti-glycine receptor antibodies if stiff-person syndrome or PERM suspected [2]
No confirmatory test exists for tetanus — diagnosis is clinical [1][3]
12. Imaging
- Imaging is generally unnecessary for diagnosis [2]
- Wound CT: May identify foreign bodies or gas locules if wound source unclear [2]
- Chest X-ray: Baseline and to assess for aspiration pneumonia
- Neuroimaging/lumbar puncture: Usually unnecessary; CSF is normal in tetanus. Consider only if meningitis or encephalitis is in the differential [2-3]
- Echocardiography: If cardiovascular instability develops — screen for Takotsubo cardiomyopathy [5]
13. Special Tests
Severity Scoring:
- Modified Ablett Classification (most widely used): [4]
- Grade 1 (Mild): Mild trismus, spasticity, no spasms, no respiratory compromise
- Grade 2 (Moderate): Moderate trismus, marked rigidity, short spasms, RR >30
- Grade 3 (Severe): Severe trismus, prolonged reflex spasms, RR >40, apnoeic spells, HR >120
- Grade 4 (Very Severe): Grade 3 features + violent autonomic disturbances (labile BP, alternating tachy/bradycardia)
- Tetanus Severity Score (TSS): Includes age, dyspnoea, time to admission, comorbidities, entry site, BP, fever; AUC 0.89 — outperforms Phillips and Dakar scores [3-4]
Microbiological (supportive only):
- RT-PCR for C. tetani neurotoxin gene from wound tissue [2]
- Wound culture (low yield; C. tetani is difficult to culture and can be present without disease) [2-3]
Spatula test: No longer recommended due to risk of precipitating laryngospasm [2]
14. ECG
- Obtain ECG on all patients — cardiovascular events occur in ~10.8% of tetanus patients [5]
- Sinus tachycardia — most common finding (autonomic hyperactivity)
- Labile heart rate — alternating tachycardia and bradycardia [2][4]
- ST-segment changes / T-wave inversions — may indicate Takotsubo cardiomyopathy or myocardial infarction [5]
- Arrhythmias — second most common cardiovascular event (19.4% of cardiac events) [5]
- Sudden cardiac arrest — reported in 16.1% of cardiovascular events; often from catecholamine surge [5]
- Continuous telemetry is essential throughout ICU stay
15. Assessment
- Generalized tetanus is the most common and most severe form of adult tetanus [2-3]
- Clinical diagnosis — no confirmatory test; based on trismus + generalized rigidity + stimulus-provoked spasms with preserved consciousness [1][3]
- Severity stratification via Ablett classification guides management intensity; 60% of patients in some series present as Grade 4 (very severe) [7]
- Atypical presentations: Isolated rigid abdomen mimicking acute abdomen; voice changes as early symptom; absence of identifiable wound in up to 30% [2-3]
- Complications: Respiratory failure, ANSD, Takotsubo cardiomyopathy, rhabdomyolysis/AKI, aspiration pneumonia, nosocomial infections, VTE, fractures from spasms, PRES [2-3][5]
- Case fatality rate: ~5–50% depending on access to ICU care; as low as 2.4% in well-resourced, high-volume centers; ~10–20% in modern facilities [2][9]
- Recovery takes 4–6 weeks for inhibitory neurotransmission to be restored [2]
16. Treatment Plan
Immediate Stabilization (ED):
- Airway: Assess for laryngospasm/airway compromise; prepare for early intubation if severe trismus, dysphagia, or apnoeic spells [2-3]
- IV benzodiazepines: Diazepam 10–30 mg IV, repeat q1–4h PRN for spasm control [3]
- Minimize stimulation: Quiet, dark room; limit noise, light, and physical contact [1][3]
First Day of Treatment:
- hTIG 500 IU IM (single dose) [3]
- Td or Tdap 0.5 mL IM (at a different site from hTIG) [3]
- Metronidazole 500 mg IV q6h × 10 days [3]
- Wound debridement if applicable [3]
- Enteral feeding via NG tube or parenteral nutrition [3]
ICU Management:
- Titrate benzodiazepine infusion; escalate to neuromuscular blockade (vecuronium/rocuronium) if spasms refractory — requires mechanical ventilation [2-3]
- Autonomic dysfunction: Magnesium sulfate IV infusion or labetalol; arterial line and invasive hemodynamic monitoring [3]
- DVT prophylaxis: Prophylactic heparin [3]
- Echocardiography if hemodynamic instability — screen for Takotsubo [5]
- Bedside physical therapy initiated early [3]
- Benzodiazepine taper over 14–21 days once spasms diminish [3]
Pre-Discharge:
- Administer another dose of Td/Tdap before discharge; complete full vaccination series [3]
- Physical therapy and supportive psychotherapy [3]
17. Disposition
- All suspected generalized tetanus → ICU admission, even for mild (Ablett Grade 1) disease — early ICU admission is recommended given unpredictable progression [2]
- Mechanical ventilation required in 65–90% of severe cases; median duration ~16–21 days [2][7]
- Median hospital stay: ~22–30 days (longer for severe disease) [6-7]
- Specialist consultation triggers: Critical care/intensivist (mandatory), infectious disease, surgery (wound debridement), cardiology (if cardiovascular events), nephrology (if AKI)
- Discharge criteria: Resolution of spasms, stable autonomic function, tolerating oral intake, completed initial vaccination doses, adequate functional status
18. Follow Up / Return Precautions
- Complete the full tetanus vaccination series after discharge (natural infection does NOT confer immunity) [2-3]
- Follow-up timing: Outpatient visit within 1–2 weeks of discharge; ongoing physical therapy
- Expected recovery: Protracted — full neurological recovery takes 4–6 weeks minimum; most patients recover fully with sustained supportive care, even elderly patients [2]
- Return precautions: New or worsening muscle stiffness/spasms, difficulty breathing or swallowing, chest pain, palpitations, fever, decreased urine output, falls
- Long-term outcomes: 61% of ICU survivors had no lasting disability at ~4 years in one cohort; 35% required discharge to non-home settings initially [2]
- Patient counseling: Emphasize that tetanus can recur — lifelong booster adherence (Td every 10 years) is essential
References
1. What Is Tetanus?. — Zhou S, Malani P. The Journal of the American Medical Association. 2026.
2. What Is Tetanus?. — Zhou S, Malani P. The Journal of the American Medical Association. 2026.
3. What Is Tetanus?. — Zhou S, Malani P. The Journal of the American Medical Association. 2026.
4. Tetanus: Recognition and Management. — Sudarshan R, Sayo AR, Renner DR, et al. The Lancet. Infectious Diseases. 2025.
5. Tetanus: Recognition and Management. — Sudarshan R, Sayo AR, Renner DR, et al. The Lancet. Infectious Diseases. 2025.
6. Tetanus. — Ergönül Ö, Kolsuz S, Figueroa JP. Lancet. 2026.
7. Tetanus. — Ergönül Ö, Kolsuz S, Figueroa JP. Lancet. 2026.
8. Tetanus. — Yen LM, Thwaites CL. Lancet. 2019.
9. Tetanus. — Yen LM, Thwaites CL. Lancet. 2019.
10. Magnitude, Patterns, and Associated Predictors of Cardiovascular Events in Tetanus: A 2-Year, Single-Center, Ambidirectional Cohort Study Involving 572 Patients. — Pham OKN, Tran BN, Duong MC, et al. Open Forum Infectious Diseases. 2023.
11. Magnitude, Patterns, and Associated Predictors of Cardiovascular Events in Tetanus: A 2-Year, Single-Center, Ambidirectional Cohort Study Involving 572 Patients. — Pham OKN, Tran BN, Duong MC, et al. Open Forum Infectious Diseases. 2023.
12. Management and Outcome of Adult Generalized Tetanus Patients in a Tertiary Hospital in Anhui, China: A Retrospective Study. — Huang J, Cai E, Ding W, et al. Frontiers in Public Health. 2025.
13. Management and Outcome of Adult Generalized Tetanus Patients in a Tertiary Hospital in Anhui, China: A Retrospective Study. — Huang J, Cai E, Ding W, et al. Frontiers in Public Health. 2025.
14. Management and Outcome of Adult Generalized Tetanus in a Chinese Tertiary Hospital. — An Y, Guo Y, Li L, et al. Frontiers in Public Health. 2023.
15. Management and Outcome of Adult Generalized Tetanus in a Chinese Tertiary Hospital. — An Y, Guo Y, Li L, et al. Frontiers in Public Health. 2023.
16. Video NeuroImage: Generalized Tetanus in a 70-Year-Old Woman. — De Marchis GM. Neurology. 2008.
17. Video NeuroImage: Generalized Tetanus in a 70-Year-Old Woman. — De Marchis GM. Neurology. 2008.
18. Prevention of Pertussis, Tetanus, and Diphtheria With Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). — Liang JL, Tiwari T, Moro P, et al. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 2018.
19. Prevention of Pertussis, Tetanus, and Diphtheria With Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). — Liang JL, Tiwari T, Moro P, et al. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 2018.